222 related articles for article (PubMed ID: 30232126)
21. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of GATA2-related myeloid neoplasms.
Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
[TBL] [Abstract][Full Text] [Related]
23. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
24. Germline Predisposition to Hematolymphoid Neoplasia.
Weinberg OK; Kuo F; Calvo KR
Am J Clin Pathol; 2019 Aug; 152(3):258-276. PubMed ID: 31309983
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with
Ciurea SO; Chilkulwar A; Saliba RM; Chen J; Rondon G; Patel KP; Khogeer H; Shah AR; Randolph BV; Perez JMR; Popat U; Hosing CM; Bashir Q; Mehta R; Al-Atrash G; Im J; Khouri IF; Kebriaei P; Champlin RE
Blood; 2018 Jun; 131(26):2989-2992. PubMed ID: 29769261
[No Abstract] [Full Text] [Related]
26. [Alert in germline mutation predisposed to myeloid neoplasm: myelodysplastic syndromes accompanied with GATA2 deficeincy syndrome].
Yao H; Yang X; Zhang X; Wang P; Deng XJ; Luo ML; Chen T; Liu YQ; Feng YM; Gao L; Kong PY
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1042-1045. PubMed ID: 35045679
[No Abstract] [Full Text] [Related]
27. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia.
Holme H; Hossain U; Kirwan M; Walne A; Vulliamy T; Dokal I
Br J Haematol; 2012 Jul; 158(2):242-248. PubMed ID: 22533337
[TBL] [Abstract][Full Text] [Related]
28. Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
Falconi G; Fabiani E; Criscuolo M; Fianchi L; Finelli C; Cerqui E; Pelosi E; Screnci M; Gurnari C; Zangrilli I; Postorino M; Laurenti L; Piciocchi A; Testa U; Lo-Coco F; Voso MT
Leuk Res; 2019 Sep; 84():106191. PubMed ID: 31386932
[TBL] [Abstract][Full Text] [Related]
29. GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations.
Green CL; Tawana K; Hills RK; Bödör C; Fitzgibbon J; Inglott S; Ancliff P; Burnett AK; Linch DC; Gale RE
Br J Haematol; 2013 Jun; 161(5):701-705. PubMed ID: 23560626
[TBL] [Abstract][Full Text] [Related]
30. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract][Full Text] [Related]
31. A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.
Fox LC; Tan M; Brown AL; Arts P; Thompson E; Ryland GL; Lickiss J; Scott HS; Poplawski NK; Phillips K; Came NA; James P; Ting SB; Ritchie DS; Szer J; Hahn CN; Schwarer A; Blombery P
Br J Haematol; 2020 Sep; 190(5):e297-e301. PubMed ID: 32488879
[No Abstract] [Full Text] [Related]
32. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
[TBL] [Abstract][Full Text] [Related]
33. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
34. Association of unbalanced translocation der(1;7) with germline GATA2 mutations.
Kozyra EJ; Göhring G; Hickstein DD; Calvo KR; DiNardo CD; Dworzak M; de Haas V; Starý J; Hasle H; Shimamura A; Fleming MD; Inaba H; Lewis S; Hsu AP; Holland SM; Arnold DE; Mecucci C; Keel SB; Bertuch AA; Tawana K; Barzilai S; Hirabayashi S; Onozawa M; Lei S; Alaiz H; Andrikovics H; Betts D; Beverloo BH; Buechner J; Čermák M; Cervera J; Haus O; Jahnukainen K; Manola KN; Nebral K; Pasquali F; Tchinda J; Turkiewicz D; Van Roy N; Zemanova Z; Pastor VB; Strahm B; Noellke P; Niemeyer CM; Schlegelberger B; Yoshimi A; Wlodarski MW
Blood; 2021 Dec; 138(23):2441-2445. PubMed ID: 34469508
[No Abstract] [Full Text] [Related]
35. Monitoring and treatment of MDS in genetically susceptible persons.
Davies SM
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):105-109. PubMed ID: 31808891
[TBL] [Abstract][Full Text] [Related]
36. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
37. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
[TBL] [Abstract][Full Text] [Related]
38. Trilineage Dysplasia in an Adolescent With Germline GATA2 Mutation.
Gardner JA; Devitt KA
J Pediatr Hematol Oncol; 2019 Jul; 41(5):392-393. PubMed ID: 30933029
[TBL] [Abstract][Full Text] [Related]
39. How I treat myelodysplastic syndromes of childhood.
Locatelli F; Strahm B
Blood; 2018 Mar; 131(13):1406-1414. PubMed ID: 29438960
[TBL] [Abstract][Full Text] [Related]
40. Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation.
Scheuermann A; Moskop A; Hopp A; Bone K; Drendel HM; Talano J; Harker-Murray P; Astle J
J Pediatr Hematol Oncol; 2022 Jul; 44(5):268-270. PubMed ID: 35235548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]